(CERS) Community Analysis from
Bulls REASONS TO BUY
Bears REASONS TO SELL
May 18, 2013
(Benzinga,
1/4/12)
Sickle cell disease is debilitating to millions of Americans, including Pittsburgh Steelers safety Ryan Clark. Although Clark only has one copy of the sickle cell gene -...(read more)
(Benzinga,
10/28/10)
Cerus Corporation (NASDAQ: CERS) today announced financial results for the third quarter ended September 30, 2010.
Revenue for the third quarter of 2010 was $5.0 million, up from $4.8 million recognized during the third quarter of...(read more)
Cerus (CERS) Company Overview
